Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its first quarter 2026 financial results. First Quarter Highlights: Revenue was $106.9 million, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results